Relyea Zuckerberg Hanson’s ResMed RMD Stock Holding History

Relyea Zuckerberg Hanson’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-824	Closed	-$226K	–	276
2025 Q3	$226K	Buy	824 +5	+0.6%	+$1.37K	0.02%	249
2025 Q2	$211K	Buy	+819	New	+$195K	0.02%	248

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Relyea Zuckerberg Hanson's RMD Position: Q4 2025 in Review

Relyea Zuckerberg Hanson sold out of ResMed (RMD) in Q4 2025, closing a stake of 824 shares — an estimated $226K sold.

Relyea Zuckerberg Hanson first reported a position in RMD in Q2 2025 and held it in 2 quarters. The position peaked at $226K in Q3 2025. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

Relyea Zuckerberg Hanson reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
Relyea Zuckerberg Hanson sold 824 ResMed shares in Q4 2025, an estimated $226K.
Relyea Zuckerberg Hanson first reported a position in ResMed in Q2 2025 and held it in 2 quarters.
Relyea Zuckerberg Hanson's ResMed position peaked at $226K in Q3 2025.
948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Relyea Zuckerberg Hanson's 13F filing for Q4 2025, filed 20 Jan 2026.